Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)

Authors:

Abstract
No abstract available
Funding Information
  • Amgen

This publication has 61 references indexed in Scilit: